Navigation Links
Eppendorf Licenses Technology for Thermal Cyclers to Bulldog Bio
Date:9/7/2011

HAMBURG, Germany, September 7, 2011 /PRNewswire/ --

Eppendorf AG has licensed patents covering gradient technology for thermal cyclers to Bulldog Bio Inc. for use in their thermal cyclers, including US patent Nos. 6,767,512 and 7,074,367. Eppendorf utilizes the technology in its Eppendorf Mastercycler® pro gradient, Mastercycler gradient and Mastercycler ep realplex models.

Eppendorf AG, based in Hamburg, Germany, develops, produces and distributes instruments and consumables for the Life Science research industry. Additional information is available at:  http://www.eppendorf.com.

Contact:
Sven Bülow, Ph.D.
Executive Vice President
Corporate Development
Eppendorf AG
Barkhausenweg 1
22339 Hamburg
Germany
Phone: +49-40-53801-500
Fax: +49-40-53801-757
e-mail: buelow.s@eppendorf.de


'/>"/>
SOURCE Eppendorf AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union
2. Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health
3. EdeniQ Licenses Yeast Technology from USDA
4. SynapDx Corporation Licenses Autism Diagnostic Discoveries From Childrens Hospital Boston
5. Cellular Dynamics Licenses Technology From ViaCyte
6. China PharmaHub In-Licenses Universal Donor Red Blood Cells Technology Exclusively From University of California, San Diego
7. Stemline Therapeutics Licenses Phase I/II Brain Cancer Vaccine - Shows Promise in Clinical Trial Conducted at University of Pittsburgh
8. Cellectis Plant Sciences Licenses Plant Transformation Technology for Corn and Rice
9. Cellectis Plant Sciences Licenses Plant Transformation Technology From Midwest Oilseeds
10. Auxogyn Licenses Non-invasive Embryo Assessment Technology From Stanford University
11. NEURO-BIOTECH DISCLOSES ITS LIST OF LICENSES
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
Breaking Biology News(10 mins):